Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against Helicobacter pylori Infection
- 1 June 1998
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 66 (6) , 2879-2886
Abstract
To determine the optimal inductive sites for immunization against Helicobacter pylori infection, the protective efficacy of recombinant urease (rUre) was assessed for mice given the vaccine by either the oral (p.o.), intranasal (i.n.), or rectal route. When mice were immunized with rUre (25 μg p.o. or rectally or 10 μg i.n.) plus heat-labile toxin from Escherichia coli as the mucosal adjuvant, all routes afforded protection against challenge with H. pylori , as indicated by a significant reduction in gastric urease activity ( P < 0.0005) compared to that of sham-immunized controls. Quantitative H. pylori culture of stomach tissue demonstrated a >97% reduction in bacterial burden in mice immunized by all routes ( P < 0.05). Induction of antiurease immunoglobulin A (IgA) levels in gastric luminal secretions after p.o. immunization was greater than after i.n. administration (means, 6.0 and 1.02 ng/ml, respectively) and was dependent upon challenge with H. pylori . However, immunization by the rectal route resulted in the generation of the highest levels of gastric antiurease IgA (mean, 40.89 ng/ml), which was detectable prior to challenge with H. pylori . Immunohistochemical staining of stomach tissue for cells secreting urease-specific antibody and CD4 + T cells showed levels of recruitment to be dependent upon challenge with H. pylori and equivalent for all routes. These results identify both the rectum and nasal passages as suitable inductive sites for urease immunization.Keywords
This publication has 21 references indexed in Scilit:
- Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infectionVaccine, 1997
- Density of Helicobacter pylori Infection In Vivo as Assessed by Quantitative Culture and HistologyThe Journal of Infectious Diseases, 1996
- Oral Immunization with Recombinant Helicobacter pylori Urease Induces Secretory IgA Antibodies and Protects Mice from Challenge with Helicobacter felisThe Journal of Infectious Diseases, 1995
- Immunisation against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?Zentralblatt für Bakteriologie, 1993
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993
- Protection by human milk IgA against Helicobacter pylori infection in infancyThe Lancet, 1993
- Geographic distribution and association with gastric cancer1993
- Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunizationVaccine, 1993
- Compliance, Adverse Events and Antibiotic Resistance in Helicobacter pylori TreatmentScandinavian Journal of Gastroenterology, 1993
- Helicobacter pylori in children with peptic ulcer and their familiesDigestive Diseases and Sciences, 1991